Patents by Inventor Shelley R. Rabel

Shelley R. Rabel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline Efavirenz
    Patent number: 6673372
    Abstract: The potent reverse transcriptase inhibitor Efavirenz is produced in crystalline form. Crystalline Efavirenz exists in several physical forms which are-designated Forms 1, 2, 3 and 4, and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: January 6, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Lilian A. Radesca, Michael B. Maurin, Shelley R. Rabel, James R. Moore
  • Crystalline (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quinazolinone
    Patent number: 6225317
    Abstract: The potent reverse transcriptase inhibitor (−)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quinazolinone is produced in solvate and crystalline form. These forms are designated Forms 1 and 2, and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).
    Type: Grant
    Filed: November 18, 1999
    Date of Patent: May 1, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Shelley R. Rabel, Mona Patel, Rodney Lawrence Parsons, Jr.